Related Experiment Video
Updated: May 11, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
Electron microscopy structure of human APC/C(CDH1)-EMI1 reveals multimodal mechanism of E3 ligase shutdown
Jeremiah J Frye1, Nicholas G Brown, Georg Petzold
11Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Abstract:
The anaphase-promoting complex/cyclosome (APC/C) is a ~1.5-MDa multiprotein E3 ligase enzyme that regulates cell division by promoting timely ubiquitin-mediated proteolysis of key cell-cycle regulatory proteins. Inhibition of human APC/C(CDH1) during interphase by early mitotic inhibitor 1 (EMI1) is essential for accurate coordination of DNA synthesis and mitosis. Here, we report a hybrid structural approach involving NMR, electron microscopy and enzymology, which reveal that EMI1's 143-residue C-terminal domain inhibits multiple APC/C(CDH1) functions. The intrinsically disordered D-box, linker and tail elements, together with a structured zinc-binding domain, bind distinct regions of APC/C(CDH1) to synergistically both block the substrate-binding site and inhibit ubiquitin-chain elongation. The functional importance of intrinsic structural disorder is explained by enabling a small inhibitory domain to bind multiple sites to shut down various functions of a 'molecular machine' nearly 100 times its size.
Insights
Early mitotic inhibitor 1 (EMI1) uses its disordered C-terminal domain to inhibit the anaphase-promoting complex/cyclosome (APC/C). This mechanism ensures accurate cell division by blocking substrate binding and ubiquitin chain elongation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The anaphase-promoting complex/cyclosome (APC/C) is a crucial E3 ligase regulating cell division through proteolysis.
- Early mitotic inhibitor 1 (EMI1) inhibits APC/C(CDH1) during interphase, coordinating DNA synthesis and mitosis.
Purpose of the Study:
- To elucidate the structural mechanism by which EMI1 inhibits APC/C(CDH1) function.
- To understand the role of intrinsic disorder in EMI1's inhibitory action.
Main Methods:
- Hybrid structural approach combining Nuclear Magnetic Resonance (NMR) and electron microscopy.
- Enzymological assays to assess APC/C(CDH1) activity.
Main Results:
- EMI1's C-terminal domain inhibits multiple APC/C(CDH1) functions.
- Disordered elements and a structured zinc-binding domain of EMI1 bind distinct APC/C(CDH1) regions.
- Synergistic inhibition involves blocking substrate binding and ubiquitin-chain elongation.
Conclusions:
- Intrinsic structural disorder in EMI1 is key to its inhibitory strategy.
- A small inhibitory domain effectively shuts down a large molecular machine by binding multiple sites.
- This provides insight into cell-cycle regulation and molecular machine inhibition.
More Related Videos
07:59Preparation of Nucleosome Core Particles Complexed with DNA Repair Factors for Cryo-Electron Microscopy Structural Determination
Published on: August 17, 2022
10:50Using In Vitro Fluorescence Resonance Energy Transfer to Study the Dynamics Of Protein Complexes at a Millisecond Time Scale
Published on: March 14, 2019
Related Concept Videos
Anaphase Promoting Complex
Export of Misfolded Proteins out of the ER
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Structure of Cadherins
Pinching-off of Coated Vesicles